Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Piantoni

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Frontiers in Medicine|March 17, 2023
Editorial: Rheumatoid arthritis: Pathogenesis and target-treatmentsSilvia Piantoni, Sarah Ohrndorf
Frontiers in Medicine|October 10, 2022
Editorial: Women in science-Rheumatology 2021Silvia Piantoni, Garifallia Sakellariou
Rheumatology (Oxford, England)|February 22, 2022
Rituximab-a B cell targeted therapy in systemic lupus erythematosus: where do we stand?Silvia Piantoni, Peter Korsten
Lupus|February 16, 2021
Improvement of lupus-associated fatigue with modafinil: Report of two casesPeter Korsten, Silvia Piantoni
Frontiers in Medicine|March 12, 2024
Editorial: Women in science - rheumatology 2023Garifallia Sakellariou, Silvia Piantoni
Frontiers in Medicine|April 2, 2024
Editorial: Into the heart of systemic autoimmune diseasesMicaela Fredi, Silvia Piantoni, Antonio Brucato, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 6, 2015
CD8+ T cell profiles in patients with rheumatoid arthritis-the effects of costimulation blockade: comment on the article by Carvalheiro et alPaolo Airò, Enrico Colombo, Silvia Piantoni, et al.
Rheumatology International|May 31, 2015
Circulating CD4+ T-cell number decreases in rheumatoid patients with clinical response to rituximabSilvia Piantoni, Mirko Scarsi, Angela Tincani, et al.
Journal of Clinical Medicine|June 24, 2022
Rapid Response of Refractory Systemic Lupus Erythematosus Skin Manifestations to Anifrolumab-A Case-Based Review of Clinical Trial Data Suggesting a Domain-Based Therapeutic ApproachMarlene Plüß, Silvia Piantoni, Chris Wincup, et al.
Clinical and Experimental Rheumatology|December 4, 2015
Serum levels of granzyme B decrease in patients with rheumatoid arthritis responding to abataceptEnrico Colombo, Mirko Scarsi, Silvia Piantoni, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Frontiers in Medicine|March 17, 2023
Editorial: Rheumatoid arthritis: Pathogenesis and target-treatmentsSilvia Piantoni, Sarah Ohrndorf
Frontiers in Medicine|October 10, 2022
Editorial: Women in science-Rheumatology 2021Silvia Piantoni, Garifallia Sakellariou
Rheumatology (Oxford, England)|February 22, 2022
Rituximab-a B cell targeted therapy in systemic lupus erythematosus: where do we stand?Silvia Piantoni, Peter Korsten
Lupus|February 16, 2021
Improvement of lupus-associated fatigue with modafinil: Report of two casesPeter Korsten, Silvia Piantoni
Frontiers in Medicine|March 12, 2024
Editorial: Women in science - rheumatology 2023Garifallia Sakellariou, Silvia Piantoni
Frontiers in Medicine|April 2, 2024
Editorial: Into the heart of systemic autoimmune diseasesMicaela Fredi, Silvia Piantoni, Antonio Brucato, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 6, 2015
CD8+ T cell profiles in patients with rheumatoid arthritis-the effects of costimulation blockade: comment on the article by Carvalheiro et alPaolo Airò, Enrico Colombo, Silvia Piantoni, et al.
Rheumatology International|May 31, 2015
Circulating CD4+ T-cell number decreases in rheumatoid patients with clinical response to rituximabSilvia Piantoni, Mirko Scarsi, Angela Tincani, et al.
Journal of Clinical Medicine|June 24, 2022
Rapid Response of Refractory Systemic Lupus Erythematosus Skin Manifestations to Anifrolumab-A Case-Based Review of Clinical Trial Data Suggesting a Domain-Based Therapeutic ApproachMarlene Plüß, Silvia Piantoni, Chris Wincup, et al.
Clinical and Experimental Rheumatology|December 4, 2015
Serum levels of granzyme B decrease in patients with rheumatoid arthritis responding to abataceptEnrico Colombo, Mirko Scarsi, Silvia Piantoni, et al.
Pageof 7